Scientific Intake Announces Management and Board Changes
Medical device and digital health company elects successful business veterans to governance and operational roles
Scientific Intake, a company dedicated to developing innovative technology for weight management, announced that William Longley, Founder and Chairman of the Board has resigned from the Board and as an officer of the Company. The Board has elected Patricia K. Scheller as the Chairwoman of the Board and Ronald T. Self as Interim Chief Executive Officer.
Scientific Intake, which sells the patented SmartByte®, the first FDA-cleared, non-invasive, removable weight management device, welcomed Mr. Self and Ms. Scheller to its board earlier this year.
Ms. Scheller stated, “The Board and I want to thank Bill Longley for his many contributions to Scientific Intake. He established the company, oversaw the clinical testing that established the ability of SmartByte to significantly reduce caloric intake and guided the company to its regulatory clearance by the FDA. We reluctantly support his decision to step down.”
Ms. Scheller, former CEO of Viveve, has a proven track record of identifying and establishing untapped new markets and business opportunities. She led the successful global launch of the first coronary stent to achieve $1B in annual sales; oversaw a novel women’s health product; and worked to expand Band-Aid® Brand wound care products into new home health care direct-to-consumer channel. She spent 15 years at Johnson & Johnson and brings operational experience as CEO in several start-up companies, including Viveve, which she took public and listed to Nasdaq.
Ms. Scheller holds a B.S.E. degree in Biomedical Engineering from Duke University and has completed executive education programs at Massachusetts Institute of Technology, Harvard University, Columbia University and Northwestern University.
Mr. Self, who currently consults with leading private equity firms, brings a wealth of sales, marketing and operating knowledge to the board. Over the past 15 years, he has partnered with middle-market private equity investors as CEO to lead their business technology services companies. He has driven the professional transformation and growth of numerous companies — increasing profitability and successfully selling four. Previously, Mr. Self-began his career in various field sales, marketing and general management positions at Procter & Gamble, Pepsi-Cola and Coca-Cola USA.
Mr. Self holds a B.B.A. in Marketing from the University of Houston and completed graduate studies at Darden and Emory Universities. He has been recognized for his intuitive leadership by American Executive magazine.
Unlike weight management devices that must be surgically implanted, SmartByte is designated as a Non-Significant Risk product by the U.S. Food and Drug Administration. It combines a simple, user-controlled medical device to modify behavior, a proprietary sensor to keep track of progress towards goal weight and one-on-one, personal coaching to support users.